According to Adamis Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is HK$39.98 Million. In 2022 the company made a revenue of HK$37.89 Million a decrease over the revenue in the year 2021 that were of HK$60.19 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.